TWIST BIOSCIENCE CORP (TWST)
Health Care · Synthetic Biology / DNA Synthesis · NASDAQ
Twist Bioscience is a synthetic DNA synthesis platform company that enables the design and production of custom DNA molecules for drug development, diagnostics, and research applications.
What TWIST BIOSCIENCE CORP does
Twist Bioscience develops and manufactures synthetic DNA using a proprietary platform technology. The company serves multiple markets including therapeutics and biologic drug discovery, diagnostics, academic and industrial research, and global supply partners. Twist leverages its DNA synthesis infrastructure to enable customers to accelerate product development, reduce turnaround times, and lower costs. The company is expanding internationally and investing in manufacturing capacity, including facilities like Wilsonville, Oregon, while integrating AI and machine learning to improve operational efficiency.
Themes: ["Synthetic biology","DNA synthesis and manufacturing","Therapeutics and biologic drug discovery","Diagnostics","Applied research and genomics","AI and machine learning in biotech"]
Fundamentals
- Price$93.67 as of 2026-07-09 close
- Market cap$5.8B as of 2026-07-10
- 1-year return+139.4% as of 2026-07-09 close
- Net margin-19.9% as of 2026-07-10
- Gross margin+52.1% as of 2026-07-10
- ROE-17.5% as of 2026-07-10
- Debt / equity0.00 as of 2026-07-10
- Revenue growth (YoY)+17.8% as of 2026-07-10
- Beta2.14 as of 2026-07-10
Key risks (from latest filing)
["Ability to scale manufacturing and increase DNA production capacity while maintaining cost reductions and gross margins as the company grows","Competitive pressure and rapid technology changes requiring continuous innovation in DNA synthesis capabilities and platform features","Regulatory compliance complexity across international markets, particularly in the European Union and other key jurisdictions"]
Competitors & peers
- Ginkgo Bioworks
- Intrexon (now Precigen)
- Synthetic Genomics
- Codexis
- Intrinsic Therapeutics
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.